Stock Rich List
#192 on the corporate holders of 809 holders

Broadwood Partners, L.P.

10% owner at STAAR Surgical; Director at Lineage Cell Therapeutics; 10% owner at Insight Molecular Diagnostics.

$861M
in disclosed stock, −$8.8M (−1.01%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
192nd of 809
Companies held
3
Largest holding
STAA, 89.6% of total
Latest SEC filing
Nov 17, 2026
Listed but not counted
$380M

What the $861M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
STAAR Surgical STAA
Common Stock
Directly15,426,144$25.03$386M44.8%Form 4, Jan 8, 2026
STAAR Surgical STAA
Common Stock
Indirectly (see filing footnote)15,426,144$25.03$386M44.8%Form 4, Jan 8, 2026
Lineage Cell Therapeutics LCTX
Common Shares
Directly50,560,992$0.82$41.5M4.8%Form 4, Nov 17, 2026
Insight Molecular Diagnostics IMDX
Common Stock, no par value
Directly16,113,455$1.66$26.7M3.1%Form 4, Nov 17, 2026
Insight Molecular Diagnostics IMDX
Common Stock, no par value
Indirectly (see filing footnote)12,684,884$1.66$21.1M2.4%Form 4, Apr 27, 2026

Share counts are the amounts Broadwood Partners, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Broadwood Partners, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
STAAR Surgical STAA
Common Stock
Through Broadwood Partners, L.P.
Held by a company or fund the insider manages
12,455,264$25.03$312M—Form 4, Mar 31, 2025
Lineage Cell Therapeutics LCTX
Common Shares
Through Broadwood Partners, L.P.
Held by a company or fund the insider manages
50,560,992$0.82$41.5M—Form 4, Nov 17, 2026
Insight Molecular Diagnostics IMDX
Common Stock, no par value
Through Broadwood Partners, L.P.
Held by a company or fund the insider manages
16,113,455$1.66$26.7M—Form 4, Nov 17, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 17, 2026BoughtIMDX3,428,571$1.75$6.0MView
Nov 17, 2026BoughtLCTX1,000,000$0.77$771KView
Apr 27, 2026BoughtIMDX250,923$3.64$913KView
Apr 24, 2026BoughtIMDX38,880$3.53$137KView
Apr 23, 2026BoughtIMDX280,381$3.50$981KView
Jan 8, 2026BoughtSTAA3,240$21.94$71KView
Jan 7, 2026BoughtSTAA66,467$22.00$1.5MView
Jan 6, 2026BoughtSTAA150,000$22.38$3.4MView
Jan 6, 2026BoughtSTAA186,946$21.01$3.9MView
Nov 21, 2025BoughtSTAA797,486$27.86$22.2MView
Nov 20, 2025BoughtSTAA393,382$27.14$10.7MView
Nov 19, 2025BoughtSTAA309,132$26.42$8.2MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
189Tco Group Holdings, L.P.
10% owner, InnovAge Holding
$901M$0 (0.00%)
190CD&R Fund X Waterworks B1, L.P.
10% owner, Core & Main
$882M−$11.4M (−1.28%)
191Leonard Green & Partners, L.P.
10% owner, WESCO International
$873M−$19.4M (−2.17%)
192Broadwood Partners, L.P.
10% owner, STAAR Surgical
$861M−$8.8M (−1.01%)
193American International Group, Inc.
10% owner, Corebridge Financial
$855M−$23.9M (−2.72%)
194STEINER LEISURE Ltd
Director, OneSpaWorld Holdings
$838M−$28.4M (−3.28%)
195Glencore plc
10% owner, Century Aluminum
$837M−$36.0M (−4.13%)

Other STAAR Surgical insiders

All STAA insiders

Questions

How much stock does Broadwood Partners, L.P. own?

Broadwood Partners, L.P. holds $861,498,025 in listed stock based on SEC filings and current prices, mostly STAAR Surgical (STAA). That ranks 192nd on the Stock Rich List.

Is this Broadwood Partners, L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Broadwood Partners, L.P. last buy or sell stock?

The most recent open-market trade on file is a purchase of 3,428,571 IMDX shares on Nov 17, 2026 at $1.75.

Files jointly with SEC filer 1278388.